Clinical Study Evaluating Outcomes of Reverse Shoulder Arthroplasty With SMR Stemless
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorArthro Medics AG
About this trial
The objectives of this study are the assessment of the clinical, radiographical and patient-reported outcomes of SMR Stemless Reverse Shoulder Arthroplasty (LimaCorporate S.p.A.) used as standard of care over a period of at least 2 years of follow-up and the evaluation of the incidence of any complication.
Eligibility criteria
Qualifiers
rotator-cuff arthropathy, osteoarthritis
approving written informed consent
Disqualifiers
Female patients who are pregnant, nursing, or planning a pregnancy.
All adult patients with any of the SMR Stemless contraindication for use for the reverse configuration as reported in the current local Instruction for use.
not consenting in participating in this study
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
1Arthro Medics AG4054, BaselCanton of Basel-City, Switzerland
Sponsors and collaborators
Arthro Medics AG
Lead sponsor
Source ClinicalTrials.gov